Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Male pattern baldness may predict prostate cancer risk.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Large prostates link to more hair loss.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Lespedeza cuneata extract may help treat enlarged prostate.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Dosing time affects finasteride's effectiveness and safety in rats.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Kolaviron and quercetin may help treat prostate issues.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

PSA screening's effectiveness in reducing prostate cancer deaths can vary based on trial design and participant compliance.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.